Patti M. Raney
Centers for Disease Control and Prevention(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, Antimicrobial Resistance in Staphylococcus, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Use and Resistance
Most-Cited Works
- → Characterization of Clinical Isolates ofKlebsiella pneumoniaefrom 19 Laboratories Using the National Committee for Clinical Laboratory Standards Extended-Spectrum β-Lactamase Detection Methods(2001)195 cited
- → Testing for Induction of Clindamycin Resistance in Erythromycin-Resistant Isolates of Staphylococcus aureus(2005)179 cited
- → Mechanisms of Decreased Susceptibility to Cefpodoxime in Escherichia coli(2002)89 cited
- → Evaluation of the NCCLS Extended-Spectrum β-Lactamase Confirmation Methods forEscherichia coliwith Isolates Collected during Project ICARE(2003)76 cited
- → In Vitro Activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a Challenge Panel of Staphylococci and Enterococci, Including Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Resistant Enterococcus faecium(2003)68 cited
- → Utility of NCCLS Guidelines for Identifying Extended-Spectrum β-Lactamases in Non- Escherichia coli and Non- Klebsiella spp. of Enterobacteriaceae(2004)55 cited
- → Anhydrolide Macrolides. 1. Synthesis and Antibacterial Activity of 2,3-Anhydro-6-O-methyl 11,12-Carbamate Erythromycin A Analogues(1998)42 cited
- → Identification of Some Charcoal-Black-Pigmented CDC Fermentative Coryneform Group 4 Isolates asRothia dentocariosaand Some asCorynebacterium aurimucosum: Proposal ofRothia dentocariosaemend. Georg and Brown 1967,Corynebacterium aurimucosumemend. Yassin et al. 2002, andCorynebacterium nigricansShukla et al. 2003 pro synon.Corynebacterium aurimucosum(2004)29 cited
- → Accuracy and Appropriateness of Antimicrobial Susceptibility Test Reporting for Bacteria Isolated from Blood Cultures(2004)25 cited
- → Anhydrolide Macrolides. 2. Synthesis and Antibacterial Activity of 2,3-Anhydro-6-O-methyl 11,12-Carbazate Erythromycin A Analogues(1998)20 cited